Gardasil, manufactured by Merck & Co, also known as Silgard was approved in the America on June 8, 2006 by FDA. In 2008, Gardasil vaccine was approved in 41 of U.S. states and 120 other countries. The FDA recommends vaccination before adolescence and potential sexual activity. The British Medical Journal published a new study revealing that Merck & Co. did not test Gardasil for human paillomarvirus HPV vaccine on women’s reproductive systems.
One young woman in Australia found her ovaries were completely unable to recover from the damage done by the vaccine. Her ovaries shut down and early menopause set in. Components of the vaccine, poylsorbate 80 and an amino acid L-histadine are the agents which lead to serious side effects when injected into muscle tissue. The information about the vaccine, obtained by Australian Therpeutic Goods Adminstration (TGA), the equivalent to American Food and Drug Administration (FDA), revealed that Merck never tested it for safety for woman’s ovaries to reproduce
DEPO-PROVERA: DEADLY REPRODUCTIVE VIOLENCE AGAINST WOMEN, Rebecca Project for Human Rights (June 2013)
Sweden first had Depo Provera testing in Africa in 1982. Over the last thirty years, United States Agency for International Development (USAID), World Health Organization (WHO) and private foundations have failed to respect US law and FDA statutes and regulations by enforcing mandatory information on Depo Provera’s Black Box warnings. Regrettably, Israel used draconian policies to radically reduce the number of Black births using Depo Provera, while willfully disregarding Depo Provera’s dangerous health impacts and this has become foundation of ongoing U.S. domestic and global family-planning strategy for women of color.
Sorry we couldn't complete your registration. Please try again.
You must accept the Terms and conditions to register